侵袭性真菌病在造血干细胞移植患者中发病率及相关病死率仍较高,随着移植类型、预处理治疗、真菌预防治疗的应用等因素的变化,真菌感染的流行病学也发生了变化;对造血干细胞移植患者合理选择方案,能够降低移植后真菌相关病死率;该综述简述了造血干细胞移植患者中侵袭性真菌病的流行病学概况、抗真菌药物种类的发展及治疗策略的更新,同时指出了目前真菌治疗方面存在的不足,并预测了下一步的研究方向。
The incidence rate of invasive fungal disease(IFD)is still high in patients with hematopoietic stem cell transplantation,leading to the high morbidity and mortality.Epidemiology of the fungal infections has changed with shifts in hematopoietic stem cell sources,pretreatment,and antifungal prophylaxis.Reasonable remedy could decrease the IFD-related mortality of the patients with hematopoietic stem cell transplantation.This article discusses the epidemiology of the IFD,development of the types of antifungal agents,and treatment strategies;in addition,it revealed the inadequate aspects of the current antifungal treatments and predicted the direction of further study.